DENTSPLY SIRONA (NASDAQ:XRAY) Cut to “Hold” at Jefferies Financial Group

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report released on Thursday, MarketBeat Ratings reports. They presently have a $20.00 price objective on the medical instruments supplier’s stock, down from their previous price objective of $30.00. Jefferies Financial Group’s price objective suggests a potential upside of 3.31% from the stock’s current price.

Other equities research analysts have also recently issued reports about the stock. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI reiterated an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Barrington Research reduced their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Finally, Mizuho initiated coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price for the company. Ten investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $26.67.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $19.36 on Thursday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a fifty day moving average of $18.98 and a two-hundred day moving average of $22.74. The stock has a market capitalization of $3.85 billion, a PE ratio of -9.35, a P/E/G ratio of 1.77 and a beta of 0.96. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $36.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 earnings per share. As a group, research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently made changes to their positions in the business. Pacer Advisors Inc. lifted its position in shares of DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. KBC Group NV lifted its position in shares of DENTSPLY SIRONA by 60.9% during the fourth quarter. KBC Group NV now owns 10,096 shares of the medical instruments supplier’s stock worth $192,000 after purchasing an additional 3,822 shares in the last quarter. Blue Trust Inc. lifted its position in shares of DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after purchasing an additional 707 shares in the last quarter. Sound Income Strategies LLC lifted its position in shares of DENTSPLY SIRONA by 85.0% during the fourth quarter. Sound Income Strategies LLC now owns 242,064 shares of the medical instruments supplier’s stock worth $4,594,000 after purchasing an additional 111,199 shares in the last quarter. Finally, Avior Wealth Management LLC lifted its position in shares of DENTSPLY SIRONA by 21.1% during the fourth quarter. Avior Wealth Management LLC now owns 34,400 shares of the medical instruments supplier’s stock worth $653,000 after purchasing an additional 6,000 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.